Glycotex, Inc.

Glycotex, Inc. (Glycotex) is a privately held research focused biopharmaceutical company, engaged in discovery and development of innovative drugs to accelerate human wound healing and tissue repair in acute and chronic wounds. The company focuses heavily on its research and development operations for the development of its lead product candidate, GLYC-101. This product is developed under different stages of clinical trials for external acute and chronic wounds including burn wounds, traumatic and surgical wounds, diabetic ulcers and venous ulcers. In addition, the company also develops novel therapies intended to accelerate human wound healing and tissue repair across a wide range of human applications. Glytcotex, Inc. expands patent portfolio in advanced wound healing indications. Glycotex is headquartered at Rockville in Maryland, the US.

Street: 
2275 Research Blvd.
City: 
Rockville
Postcode: 
20850
Federal State : 
United States
WebSite: 
www.glycotexinc.com
Fax: 
1-301-5765633

Company Index Score

Current Index Score Historical Index Score
  • Glycotex, Inc. currently scores 50 % in the index.
  • Glycotex, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Glycotex, Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets